|
US2019048055A1
|
|
Alt-803 in combination with anti-cd38 antibody for cancer therapies
|
|
EP3592778A1
|
|
Il-15-based fusions to il-12 and il-18
|
|
AU2017345791A1
|
|
Multimeric IL-15-based molecules
|
|
US2017342119A1
|
|
Construction and characterization of multimeric IL-15-based molecules with CD3 binding domains
|
|
AU2016326575A1
|
|
Interleukin-15 superagonist significantly enhances graft-versus-tumor activity
|
|
KR20170047221A
|
|
Il-15-based molecules and methods of use thereof
|
|
AU2013273643A1
|
|
Fusion molecules and il-15 variants
|
|
AU2013240191A1
|
|
Methods for treating neoplasia
|
|
AU2012201369A1
|
|
Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
|
|
AU2011305476A1
|
|
Multimeric IL-15 soluble fusion molecules and methods of making and using same
|
|
WO2010111467A1
|
|
Hiv vpr-specific t cell receptors
|
|
WO2009117117A1
|
|
T cell receptor fusions and conjugates and methods of use there of
|
|
CN104109200A
|
|
Fusion Molecules And Il-15 Variants
|
|
AU2005260004A1
|
|
Production of tissue factor in plants
|
|
CN1901839A
|
|
Soluble TCR molecules and methods of use
|
|
KR20060028382A
|
|
Transient production of pharmaceutically important proteins in plants
|
|
WO2004018619A2
|
|
P53 binding t cell receptor molecules and uses thereof
|
|
US2002198144A1
|
|
MHC complexes and uses thereof
|
|
US6534633B1
|
|
Polyspecific binding molecules and uses thereof
|
